106 related articles for article (PubMed ID: 6595865)
21. The ultrastructure of a poorly differentiated adenocarcinoma of the human tuba uterina.
Rorat E; Fenoglio C
Oncology; 1976; 33(4):167-9. PubMed ID: 1018880
[TBL] [Abstract][Full Text] [Related]
22. Papillary serous tumors of the ovary: an electron microscopic study.
Blaustein A
Gynecol Oncol; 1976 Sep; 4(3):314-23. PubMed ID: 964700
[No Abstract] [Full Text] [Related]
23. Radioimmunoassay of the CA 12 5 antigen in ovarian carcinomas: advantages compared with CA 19-9 and CEA.
Ricolleau G; Chatal JF; Fumoleau P; Kremer M; Douillard JY; Curtet C
Tumour Biol; 1984; 5(3-4):151-9. PubMed ID: 6594738
[TBL] [Abstract][Full Text] [Related]
24. Immunologic studies of human serous cystadenocarcinoma of ovary. Demonstration of tumor-associated antigens.
Bhattacharya M; Barlow JJ
Cancer; 1973 Mar; 31(3):588-95. PubMed ID: 4632680
[No Abstract] [Full Text] [Related]
25. Characterization of a human ovarian carcinoma cell line, OTN 14, derived from a mucinous cystadenocarcinoma.
van Niekerk CC; Poels LG; Jap PH; Smeets DF; Thomas CM; Ramaekers FC; Vooijs GP
Int J Cancer; 1988 Jul; 42(1):104-11. PubMed ID: 3292443
[TBL] [Abstract][Full Text] [Related]
26. [Relationship between serum levels and immunohistological tissue levels of CA 125 and CEA in epithelial ovarian cancers: its implications for tumor cell type specificity].
Oishi T; Maruo T; Iwasaki M; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1595-604. PubMed ID: 3464659
[TBL] [Abstract][Full Text] [Related]
27. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
[TBL] [Abstract][Full Text] [Related]
28. Ovarian tumor antigens: preliminary histological investigation.
Daunter B; Jaa-Kwee D; Miklosi S; Wright G
Gynecol Oncol; 1986 Mar; 23(3):364-70. PubMed ID: 3514391
[TBL] [Abstract][Full Text] [Related]
29. Antigen detection by the monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patients' sera.
Dietel M; Arps H; Klapdor R; Müller-Hagen S; Sieck M; Hoffmann L
J Cancer Res Clin Oncol; 1986; 111(3):257-65. PubMed ID: 3460995
[TBL] [Abstract][Full Text] [Related]
30. A new human ovarian carcinoma cell line: establishment and analysis of tumor-associated markers.
Horowitz AT; Treves AJ; Voss R; Okon E; Fuks Z; Davidson L; Biran S
Oncology; 1985; 42(5):332-7. PubMed ID: 2412195
[TBL] [Abstract][Full Text] [Related]
31. A study of the Ca antigen in epithelial tumours of the ovary.
Ferguson AM; Fox H
J Clin Pathol; 1984 Jan; 37(1):6-9. PubMed ID: 6368598
[TBL] [Abstract][Full Text] [Related]
32. Argyrophilia in ovarian serous tumors. A comparative study in 127 epithelial ovarian tumors.
Lin M; Hanai J; Wada A; Ozaki M; Nasu K; Okamoto S; Matsumoto K
Histol Histopathol; 1991 Oct; 6(4):477-84. PubMed ID: 1804424
[TBL] [Abstract][Full Text] [Related]
33. Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies.
Tsuji Y; Suzuki T; Nishiura H; Takemura T; Isojima S
Cancer Res; 1985 May; 45(5):2358-62. PubMed ID: 2580620
[TBL] [Abstract][Full Text] [Related]
34. CA-125 in gynecological malignancies.
Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):713-7. PubMed ID: 2443359
[TBL] [Abstract][Full Text] [Related]
35. Immunocytochemical determination of EGFR, OV 632 and OC 125 in primary ovarian cancer patients.
Athanassiadou P; Athanassiades P; Kyrkou K; Lazaris D; Kyragiannis G; Petrakakou E; Michalas S
Oncology; 1995; 52(2):145-9. PubMed ID: 7854775
[TBL] [Abstract][Full Text] [Related]
36. OC-125 as a diagnostic aid in the cytological evaluation of ascitic cells in patients with ovarian carcinoma.
Skov RV; Bichel P
Virchows Arch A Pathol Anat Histopathol; 1991; 419(1):59-62. PubMed ID: 2068803
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibody, Mab 12C3, is a sensitive immunohistochemical marker of early malignant change in epithelial ovarian tumors.
Yamada K; Ohkawa K; Joh K
Am J Clin Pathol; 1995 Mar; 103(3):288-94. PubMed ID: 7872250
[TBL] [Abstract][Full Text] [Related]
38. Localization of MOC-1 cell surface antigen in small-cell lung carcinoma cell lines: an immunohistochemical and immunoelectron microscopic study.
Speirs V; Eich-Bender S; Youngson CR; Cutz E
J Histochem Cytochem; 1993 Sep; 41(9):1303-10. PubMed ID: 8394853
[TBL] [Abstract][Full Text] [Related]
39. Expression of major histocompatibility antigens and nature of inflammatory cellular infiltrate in ovarian neoplasms.
Kabawat SE; Bast RC; Welch WR; Knapp RC; Bhan AK
Int J Cancer; 1983 Nov; 32(5):547-54. PubMed ID: 6358053
[TBL] [Abstract][Full Text] [Related]
40. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T
Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
